Abstract:

Pharmacies are the frontline of the pandemic and critical to maintaining public health. The emergence of COVID-19 brought unprecedented challenges and changes to all nations of the world. In the light of this, this study assessed the challenges of pharmaceutical practices in Nigeria during COVID-19. A descriptive cross-sectional survey design was adopted, and the data were collected from 1,200 respondents through the interview schedule and structured questionnaire using a systematic random sampling technique. A total of 1,118 copies of the questionnaire were retrieved, coded, and analysed using descriptive and inferential statistics aided by the SPSS software version 23. The study discovered different factors that influenced the effective practice of pharmacists during the COVID-19 pandemic. The findings of this study revealed that the majority, 591(52.9%) of the pharmacists, encountered difficulties on the road with security personnel while on essential duty and also found it ‘somewhat difficult to work during the pandemic. The results of Factor Analysis grouped the major challenges into material and financial constraints. The results showed two orthogonal factors pharmaceutical practices, which were derived with the total explanation of 65.35% of the variance. Only variables with constraints loadings of 0.70 and above were used in naming the constraints. The material constraint has the greatest impact on effective practices of pharmacists to provide treatment for illnesses during COVID-19 with a 44.16% contribution. There is a need for government and institution supports for better and effective pharmaceutical practices before, during, and after any sort of pandemic, especially in drugs supplies and financial assistance.
Keywords: Assessment, Challenges, COVID-19 Pandemic, Pharmaceutical Practices, Nigeria.

References:

[1] Ramzy, A., and McNeil, D.G., 2020, World Health Organisation declares global emergency as Wuhan coronavirus spreads. The New York Times. Accessed: 30/01/2020. https://nyti.ms/2RER70M.

[2] The New York Times, 2020, Nigeria Responds to First Coronavirus Case in Sub-Saharan Africa. 28 March 2020.

[3] Roy, R.M. et al. 2021, Psychological distress during pandemic Covid-19 among adult general population: Result across 13 countries. Clinical Epidemiology and Global Health, 10 (2021), 100708, 1-6.

https://doi.org/10.1016/j.cegh.2021.100708.

[4] Weiner, L.P., 1987, Coronaviruses: A historical perspective. In Michael, M.C.L. and Stephen, A.S. (Eds), Corona Viruses: Advances in Experimental Medicine and Biology (pp. 1-4), volume 28, Plenum Press: New York and London.

[5] International Medical Aids-IMA, 2020, Coronavirus: What you need to know. 21 April 2020. Retrieved 25 April 2020 at https://medicalaid.org/.

[6] World Health Organisation, 2020, Infection prevention and control for the safe management of a dead body in the context of COVID-19 Interim guidance 24 March 2020.

[7] Shakespeare, M., 2002, Zoonoses. London, U.K.: Pharmaceutical Press, Division of the Royal Pharmaceutical Society.

[8] Lai, J., Ma, S., Wang, Y., Cai, Z., Hu, J., Wei, N., et al. 2020, Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open, 3: e203976. Doi:10.1001/ jamanetworkopen.2020.3976.

[9] World Health Organization, 2020, Middle East respiratory syndrome coronavirus (MERS-CoV). Available: https://www.who.int/emergencies/mers-cov/en/ Accessed: 8 September 2021.

[10] WHO, 2020, Severe Acute Respiratory Syndrome (SARS) Available: https://www.who.int/csr/sars/en/ Accessed: 7 September 2021.

[11] Mila, N.N.H., Roy, R.M., Ayesha, A., Fatjona, K., Radwa, A.E., Jeldah, M.N., and Adinegara, L.A., 2020, Immediate impact of COVID-19 on mental health and its associated factors among healthcare workers: A global perspective across 31 countries. Viewpoints, 10(2), 020381, 1-6. doi: 10.7189/jogh.10.020381.

[12] WHO, 2020, Mental health and psychosocial considerations during the COVID-19 outbreak. https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf?sfvrsn=6d3578af_2;2020.

[13] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med., ;382(8):727–733. https://doi.org/10.1056/NEJMoa2001017.

[14] African Centre for Disease Control-ACDC, 2020, Coronavirus disease 2019 (COVID-19): Africa centre for disease control. Accessed: 25 August 2020. https://africacdc.org/%20covid-19/.

[15] Akande-Sholabi, W., Adebisi, Y.A., Bello, A., and Ilesanmi, O.S., 2020, COVID-19 in Nigeria: Is the pharmaceutical sector spared? Public Health in Practice, 1, 100044.

https://doi.org/10.1016/j.puhip.2020.100044.

[16] Nigeria Centre for Disease Control-NCDC, 2021, First case of corona virus disease confirmed in Nigeria. 28 February 2020. Retrieved 5 June 2021.

[17] Oni, B.O., 2021b, Mitigating strategies and its challenges of COVID-19 pandemic in Ogun State, Nigeria. Texila International Journal of Public Health, 1-11. DOI: 10.21522/TIJPH.2013.09.01. Art007.

[18] Nigeria Centre for Disease and Control - NCDC, 2020a, COVID-19 Nigeria—Nigeria centre for disease control. Accessed: 11 August 2020. https://covid19.ncdc.gov.ng/.

[19] Thomson, L.A., et al., 2007, Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Annals of Pharmacotherapy, 41(9), 1411-1426.

[20] Shanmugam, S., et al., 2011, impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus. Journal of Royal Medical Society, 16(1), 412-418.

[21] Oni, O.B., 2021a, Cost-effectiveness analysis during lockdown and health belief model of COVID-19 pandemic in Ogun State, South-western Nigeria. Texila International Journal of Public Health, 1-11.

[22] Erah, P.O., and Nwazuoke, J.C., 2002, Identification of standards for pharmaceutical care in Benin City. Tropical Journal of Pharmaceutical Research, 1(2), 55-66.

[23] Oparah, C.A., and Eferakeya, A.E., 2005, Attitude of Nigerian pharmacists towards pharmaceutical care. Pharmacy World and Science, 27(3), 208-214.

[24] David, K.B., and Adebisi, Y.A., 2020, Proposed model for hospital and community pharmacy services during COVID-19 pandemic in Nigeria. Int. J. Pharm. Pract. (2020 Jul 4). https://doi.org/10.1111/ijpp.12652,10.1111/ijpp.12652.

[25] Ashiru-Oredope, D., Chan, A.H.Y., Olaoye, O., Rutter, V., Babar, Z. and the C.P.A. COVID-19 Action Team, 2020, Needs assessment and impact of COVID-19 on pharmaceutical professionals in 31 commonwealth countries. J of Pharm Policy and Pract 13, 72, 1-11. https://doi.org/10.1186/s40545-020-00275-7.

[26] Ayati, N., Saiyarsarai, P. & Nikfar, S., 2020-, Short- and long-term impacts of COVID-19 on the pharmaceutical sector. DARU J Pharm Sci, 28, 799-805. https://doi.org/10.1007/s40199-020-00358-5.

[27] Chukwuorji J.C., and Iorfa, S.K., 2020, Commentary on the coronavirus pandemic: Nigeria. Psychological Trauma: Theory, Research, Practice, and Policy, 12(S1), S188– S190. DOI 10.1037/tra0000786.

[28] Ekpenyong, A., Udoh, A., Kpokiri, E., and Bates, I., 2018, An analysis of pharmacy workforce capacity in Nigeria. Journal of Pharmaceutical Policy and Practice, 11:20. https://doi.org/10.1186/s40545-018-0147-9.

[29] International Pharmaceutical Federation-IPF, 2006, Global pharmacy workforce and migration report: A call for action. The Hague: International Pharmaceutical Federation; 2006. Available from: http://www.fip.org/files/fip/HR/FIP%20Global%20Pharmacy%20and%20Migration%20report%2007042006.PDF.

[30] Smith, F., 2009, Private local pharmacies in low- and middle-income countries: a review of interventions to enhance their role in public health. Tropical Med Int Health. 2009, 14(3), 362-72.

[31] Stenson, B., Syhakhang, L., Eriksson, B., and Tomsom, G., 2001, Real world pharmacy: Assessing the quality of private pharmacy practice in the Lao People’s Democratic Republic. Soc Sci Med. 2001, 52, 393–404.

[32] International Pharmaceutical Federation (IPF), 2015, Global pharmacy workforce intelligence: trends report. The Hague: International Pharmaceutical Federation; 2015. Available from: https://www.fip.org/files/fip/PharmacyEducation/Trends/FIPEd_Trends_report_2015_web_v3.pdf.

[33] Duggan, C., 2001, Primary and secondary care pharmacy. In: K. Taylor, and G. Harding (Eds.), Pharmacy practice (pp. 43-49). London and New York.

[34] Salami, A.A., Olorunfemi, J.F., and Olanrewaju, R.M., 2020, Geo-spatial analysis of rainfall amounts and rainy days using satellites and ground-based data in Nigeria. Journal of Meteorology and Climate Science, 18 (1).

[35] National Population Commission, 2016, 2016 Projected population of Federal Republic of Nigeria 2006 Population and Housing Census, Priority Tables, Vol. VII Abuja, Nigeria.

[36] Eze, T.C., Okpala, C.S., and Ogbodo, J.C., 2014, Patterns of inequality in human development across Nigeria’s six geo-political zones. J Dev Ctries Stud., 4(8), 97–101.

[37] World Health Organization, 2015, Nigeria: WHO statistical profile 2015. Available from: http://www.who.int/gho/countries/nga.pdf?ua=1.

[38] Ansa, V., Ekott, J., and Bassey, E., 2008, Profile and outcome of cardiovascular admissions at the University of Uyo Teaching Hospital, Uyo: A five-year review. Niger J Clin Pr., 11(3), 290.

[39] Ukoh, V., 2007, Admission of hypertensive patients at the University of Benin Teaching Hospital. Nigeria East Afr Med J., 84(7), 329–35.

[40] Onwuchekwa, A.C., and Chinenye, S., 2010, Clinical profile of hypertension at a university teaching Hospital in Nigeria. Vasc Health Risk Manag, 6, 511–6.

[41] Chankova, S., Ha, N., Chipanta, D., Kombe, G., Onoja, A., and Ogungbemi, K., 2006, A situation assessment of human resources in the public health sector in Nigeria. Bethesda: USAID and Abt Associates InC; 2006. Available from: http://pdf.usaid.gov/pdf_docs/PNADH422.pdf. Accessed 06/10/2020.

[42] Salami, A.A., 2018, Constraints to effective climate change adaptation policies and programmes in Osun State, Nigeria. Journal of Social Sciences and Humanities, 1(1), 9-14.

[43] Anol, B., 2012, Social science research: Principles, methods, and practices (2nd Edition). University of South Florida Tampa, Florida, USA. Published under the Creative Commons Attribution-
Non-Commercial-Share Alike 3.0 Unported License. 135-136. Retrieved 9th February, 2015 from http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=1002&context=oa_textbooks.

[44] Liu, Q., Luo, D., Haase, J.E., et al, 2020, The experiences of healthcare providers during the COVID-19 crisis in China: a qualitative study. The Lancet. Global health. 8(6), e790–e798.

[45] Ayanian, J.Z., 2020, Mental health needs of health care workers providing frontline COVID- 19 care. JAMA Health Forum. 2020. https://doi.org/10.1001/jamahealthforum.2020.0397 Published online April 1.